JPH0213423A - Balloon for catheter and manufacture thereof - Google Patents

Balloon for catheter and manufacture thereof

Info

Publication number
JPH0213423A
JPH0213423A JP63164196A JP16419688A JPH0213423A JP H0213423 A JPH0213423 A JP H0213423A JP 63164196 A JP63164196 A JP 63164196A JP 16419688 A JP16419688 A JP 16419688A JP H0213423 A JPH0213423 A JP H0213423A
Authority
JP
Japan
Prior art keywords
catheter
balloon
thin film
inflatable
tip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63164196A
Other languages
Japanese (ja)
Inventor
Yoshiyuki Shimamura
島村 善行
Kyogo Tsushima
恭吾 対馬
Hisato Seto
瀬戸 寿人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Okamoto Industries Inc
M&M Co Ltd Japan
Original Assignee
Okamoto Industries Inc
M&M Co Ltd Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okamoto Industries Inc, M&M Co Ltd Japan filed Critical Okamoto Industries Inc
Priority to JP63164196A priority Critical patent/JPH0213423A/en
Publication of JPH0213423A publication Critical patent/JPH0213423A/en
Pending legal-status Critical Current

Links

Landscapes

  • Endoscopes (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

PURPOSE:To enable transmission of a laser beam and to be seen through by fitting a transparent thin film body having an expansion portion formed at the forward end of a fixed portion in the same boby to the forward end of a catheter to let physiological salt water flow in the expansion portion to be expanded. CONSTITUTION:A transparent thin film body A has an expansible expansion portion 2 formed in one body at the forward end of a fixed portion 1 and elasticity. The fixed portion 1 is fixed to the forward end portion (b) of a catheter B where an endscope tube C is inserted, and the expansion portion 2 is projected from the forward end of the catheter B to cover the main body A. The expansion portion 2 comprises a spherical body having the elasticity, which is formed at the forward end of the fixed portion 1. When the main body A is fixed to the forward end portion (b) of the catheter B to be covered therewith, physiological salt water is let flow from a pouring port of a channel of an endsoope projected from the forward end and inserted in the catheter, thereby expanding the expansion portion to a designated size, so that film thickness is further decreased to enable seeing through and a laser beam such as argon laser can be transmitted.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は血管内や管腔臓器(食道、胃、−二脂腸、大腸
、鼻咽腔、胆道、腹腔、膀腔、子宮脛部など)内を観察
2診断、治療する1=めのレーザー光線治療用内視鏡を
カバーするため、この内視鏡のチューブを内部に挿入装
着せしめるカテーテルの先端に取付けて使用するバルー
ンおよびこのバルーンを製造する方法に関するものであ
る。。
Detailed Description of the Invention (Field of Industrial Application) The present invention is applicable to intravascular and luminal organs (esophagus, stomach, bifatty intestine, large intestine, nasopharynx, biliary tract, abdominal cavity, urinary cavity, uterine shin, etc.). ) Manufacture a balloon to be used by attaching it to the tip of a catheter into which the tube of the endoscope is inserted to cover the endoscope for laser beam therapy (1) to observe and treat the inside of the body (2) for diagnosis and treatment. It's about how to do it. .

(従来技術及び課題) 従来、内?Ji!鏡のデユープを挿入ゼしめるカテーテ
ル用のバルーンは無かった。したがって内視鏡のヂコー
ブを挿入装着したカテーテルを血管内ヤ)管腔臓器内に
挿入し内視鏡デユープの先端部にあるライトガイドで内
部を照らし、出血部位や病巣4丁どの患部を対物レンズ
を通して観察したり診断するか或いはチャンネルすなわ
ら処置具や治療具などを挿入する孔から光ファイバーを
挿入し、患部にレーザー光線を照射して治療していた。
(Prior art and issues) Conventionally, within? Ji! There was no balloon for the catheter to insert and close the mirror duplex. Therefore, a catheter equipped with an endoscope is inserted into the blood vessel (intravascular system) or a luminal organ, and the inside is illuminated with a light guide at the tip of the endoscope duplex, and the objective lens is used to detect bleeding sites, lesions, and other affected areas. For observation and diagnosis, an optical fiber is inserted through a channel, which is a hole into which a treatment tool or the like is inserted, and the affected area is irradiated with a laser beam for treatment.

しかしながら内視鏡ヂコーブの先端部にあるライl−ガ
イドや対物レンズ或いは光ファイバーが露呈しているた
め白液や体液2食物、肉腫2分泌物などが耐着しやすく
、汚染されて患部が見ずらかったり、照射が充分でなか
ったりしていた。又、これらの1ll=1着によって腐
蝕され充分機能を発揮しなくなるおそれ〜bあった。
However, because the light guide, objective lens, or optical fiber at the tip of the endoscope is exposed, white fluid, body fluids, food, sarcoma secretions, etc. can easily adhere to it, making it difficult to see the affected area due to contamination. Or the irradiation was not sufficient. In addition, there was a risk that 1 liter of these materials would corrode and no longer function adequately.

更にバルーンイ」カテーテルとしては特開昭63−13
9565号、同139566号、 X139!1(i7
号の各公報に記載され!こbのがある。
Furthermore, as a balloon catheter, Japanese Patent Application Laid-Open No. 63-13
No. 9565, No. 139566, X139!1 (i7
Described in each bulletin of the issue! There is this b.

しかしながら、これら公報記載のものはカブ−デル本体
が外管、中管、内管の三重管又はニー重管の構造をして
いるために内視鏡のヂコーブを内部に挿入づ−ることか
出来ず、内視鏡用カテーテルどして使用することが出来
ない。しかも、これらのバルーンは閉塞用であって、シ
リコンゴム、ポリウレタン、ラテックス等の弾性41F
Iで成形されているが、透明性の言及はなく、レーザー
光線を透過したり、透視することは出来ないものであっ
た。
However, in the cases described in these publications, because the Cavendel main body has a triple tube structure of an outer tube, a middle tube, and an inner tube, or a knee tube structure, it is difficult to insert the endoscope into the body. It cannot be used as an endoscopic catheter. Moreover, these balloons are for occlusion and are made of elastic 41F material such as silicone rubber, polyurethane, or latex.
Although it was molded with I, there was no mention of transparency, and it was impossible to transmit or see through laser beams.

(課題解決手段) 本発明は上記のような事情に鑑みてなされたもので、そ
の手段は泄いゴム体で固定部の先に膨脹部を同一体に形
成して透明性薄膜本体を設【プ、これをカテーテルの先
端に取付りて前記膨脹部に生理食塩水を流入し膨張させ
るものである。
(Means for Solving Problems) The present invention has been made in view of the above-mentioned circumstances, and its means is to form a transparent thin film body by forming an inflatable part at the end of a fixed part in the same body with a rubber body. This is attached to the tip of a catheter, and physiological saline flows into the expansion section to inflate it.

(作 用) 本発明は薄いゴム体で、固定部の先に膨脹部を同一体に
形成して透明性薄膜本体を設け、その固定部をカテーテ
ルの先端部に取付りることに」:つてカテーテル内に挿
入装着された内視鏡チューブの先端部にあるライトガイ
ド、対物レンズ、光ファイバーなどを保@づると共に、
膨脹部に生理食塩水を流入さけて眼部を膨らまずことに
よりし一ザー光線を透過せしめ、かつ透視可能どなる。
(Function) The present invention is a thin rubber body, an inflatable part is formed in the same body at the end of a fixing part, a transparent thin film body is provided, and the fixing part is attached to the distal end of a catheter. It protects the light guide, objective lens, optical fiber, etc. at the tip of the endoscope tube inserted into the catheter.
By avoiding the flow of physiological saline into the inflatable part and not inflating the eye, the laser beam can pass through the eye and it becomes possible to see through the eye.

(実施例) 本発明の実施の数形態を図面について説明づ゛ると、透
明性簿膜本体(A>は膜厚が010〜0.40 nmr
Pi1度の天然ゴム、又はシリコンゴムなどよりなる透
明な薄膜で、固定部(1)の先に#服可能な膨脹部(2
)を同一体に形成し伸縮自在性を有するもので、該固定
部(1)を内視鏡(C)のヂ」−−ブ(C)を挿入せし
めるカテーテル(B)の先端部(b)に固定し、膨脹部
(2)が、カテーテルの先端より突出させて該本体(△
)を被覆せしめる。
(Example) To explain several embodiments of the present invention with reference to the drawings, the transparent film body (A> has a film thickness of 010 to 0.40 nmr).
A transparent thin film made of natural rubber or silicone rubber with a Pi of 1 degree, and an inflatable part (2) that can be worn at the end of the fixing part (1).
) are formed in the same body and have elasticity, and the fixed part (1) is the distal end part (b) of the catheter (B) into which the endoscope (C) is inserted. The inflatable part (2) is made to protrude from the tip of the catheter and the main body (△
).

固定部(1)は−万端を開放状どじだ直径が1.0〜1
7.0tnm程度の筒形状のもので、その断面形状は円
形、隋円形、三角形、四角形、その他の多角形など任意
形状どし、必要に応じて内面又は外面に凸起、四部、凹
凸条などを形成し、他方に膨脹部(2)を同一体に設置
づ、その膨脹部(2)が突出Jるように前記開放部から
固定部(1)内に内視鏡(C)のチューブ(C)を挿入
するカテーデル(B)の先端部(b)を挿入し、手術用
糸で縛りつ(プたり、接着剤を用いたり他のイ(意の手
段で固定させる。この際、〕Jチーチル(B)の先端部
(b)の外面にすべり止めの凹凸部を設けると効果的で
ある。
The fixed part (1) is open at all ends and has a diameter of 1.0 to 1.
It has a cylindrical shape of about 7.0 tnm, and its cross-sectional shape can be any shape such as circular, circular, triangular, quadrilateral, and other polygons, and if necessary, the inner or outer surface may have convexities, four parts, uneven stripes, etc. The tube (C) of the endoscope (C) is inserted into the fixing part (1) from the open part so that the inflatable part (2) protrudes from the other end. Insert the distal end (b) of the catheter (B) into which the catheter (B) is to be inserted, and tie it with surgical thread, use adhesive, or fix it by other means. At this time, It is effective to provide anti-slip unevenness on the outer surface of the tip (b) of the chichiru (B).

膨脹部(2)は固定部(1)の先に形成した伸縮性を有
する球状体(第1図、第6図)又は膨出体(第8図)或
いは筒状体く第7図)よりなり、本体(A>をカテーテ
ル(B)の先端部(b)に被覆固定した場合、該先端よ
り突出し、カブ−チル内に挿入する内視鏡のチ1jンネ
ル又は送気送水口或いはカテーテル自身の注入口から生
1!I!食塩水を流入することにJ:って、所定の大き
さに膨111W 7するもので、膨張する前の形態にお
いて、固定部<1)、J−、すし大径状に形成する(第
6図、第8図)か、又は固定部よりわずかに小径状とす
る(第1図、第7図)か或いは略同径状とすることは任
意であり、又、形状及び径の組合せも任意である。
The expanding part (2) is formed from a stretchable spherical body (Fig. 1, Fig. 6), a bulging body (Fig. 8), or a cylindrical body (Fig. 7) formed at the end of the fixed part (1). When the main body (A) is covered and fixed to the distal end (b) of the catheter (B), the endoscope channel or air/water supply port or the catheter itself protrudes from the distal end and is inserted into the cab. When the raw 1!I! saline solution flows in from the injection port of J:, it expands to a predetermined size. It is optional to form it in a large diameter shape (FIGS. 6 and 8), or to make it slightly smaller in diameter than the fixing part (FIGS. 1 and 7), or to have approximately the same diameter, Moreover, the combination of shape and diameter is also arbitrary.

又、その径も09〜35.0mm程度と診断治療の個所
に応じた大きさであり、いずれにしても、生理食塩水の
流入によって膨張し、膜厚がさらに薄くなり透視可能で
あると共に、ヤグレーザ−、アルゴンレーザー、アルゴ
ンダイレーザーなどレーザー光線を透過出来るようにな
る。又、その膨らみで出血部位又は病巣などの患部を圧
迫して止面せしめるか或いは狭窄部を拡開せしめ、更に
血管内においては、その膨らみで血管内面に密接し、白
液の流れを止める機能も右するものである。
In addition, its diameter is approximately 09 to 35.0 mm, depending on the location of diagnosis and treatment. Becomes able to pass through laser beams such as Yag laser, argon laser, and argon dye laser. In addition, the bulge compresses and stops the affected area such as a bleeding site or lesion, or widens a stenotic area, and furthermore, within the blood vessel, the bulge comes into close contact with the inner surface of the blood vessel and stops the flow of white fluid. It is also true.

天然ゴムの薄膜は天然ゴムラテックスのゴム分100重
量部に対して粉末加硫剤0.7〜15@猷部。
The natural rubber thin film contains 0.7 to 15 parts of powdered vulcanizing agent per 100 parts by weight of the rubber content of natural rubber latex.

粉末加硫(足進助剤0,2・〜05重貫部、液状加硫促
進剤0.5〜2.0ffifi部、液状老化防止剤05
〜2.0重量部を配合した溶液に、本体(A)と同形状
をした製造型を膨脹部が下側になるように浸漬せしめた
後、引ぎ楊げて該型に天然ゴムを付着させ乾燥して固定
部(1)と膨脹部(2)とが同一体となっIC膜厚が0
.10〜O,AOmmの透明性薄膜となった伸縮性を右
するものであり、膨脹部(2)の頂面部(2)′は多少
肉厚状になる揚台がある。
Powder vulcanization (adhesive aid 0.2-05 parts, liquid vulcanization accelerator 0.5-2.0 parts, liquid anti-aging agent 05 parts)
A manufacturing mold having the same shape as the main body (A) is immersed in a solution containing ~2.0 parts by weight with the expanded part facing downward, and then pulled out to adhere natural rubber to the mold. After drying, the fixing part (1) and the expanding part (2) become one and the IC film thickness is 0.
.. This is responsible for the elasticity of the transparent thin film of 10 to 0.0 mm, and the top surface (2)' of the expansion part (2) has a platform that is somewhat thick.

本発明の基本的描成は前述の如く固定部(1)の先に膨
脹部(2)を同一体に形成した透明性薄膜本体(A>よ
りなるものであるが、固定部(1)と膨脹部(2)との
間にくびれ部(3)を設置Jたり(第1図、第10図)
、又は膨脹部(2)に破れ防止膜(4)を設けたり(第
9図、第10図)、或いはくびれ部(3)と破れ防止膜
(4)とを設()たり(第10図)?l−ることが出来
るものである。
As mentioned above, the basic concept of the present invention is that it consists of a transparent thin film body (A>) in which the expansion part (2) is integrally formed at the end of the fixing part (1), but the fixing part (1) and Install the constriction part (3) between the expansion part (2) (Fig. 1, Fig. 10)
, or the expansion part (2) is provided with a tear prevention film (4) (Figs. 9 and 10), or the constriction part (3) and a tear prevention film (4) are provided (Fig. 10). )? l- It is something that can be done.

すなわち、くびれ部(3)は筒状固定部(1)と球状膨
脹部(2)との間に形成された小径部であり、固定部の
径に対して約75〜85%(平均的に80%)程度の割
合となる径であって、その膜厚は固定部及び膨脹部の膜
厚よりもわずかではあるが肉厚く形成されている。
That is, the constriction part (3) is a small diameter part formed between the cylindrical fixing part (1) and the spherical expansion part (2), and is about 75 to 85% (on average) of the diameter of the fixing part. 80%), and its thickness is slightly thicker than that of the fixed part and the expansion part.

筒状固定部(1)2球状膨脹部(2)、頂面部(2>’
 、<びれ部(3)にお(プる膜厚と各部にお(〕る内
径(X)(Y)(Z)、全体の長ざ(Jり、<びれ部迄
の長さ(m)の関係について、その数例を下記に示すが
、これに限定されるものではない。
Cylindrical fixed part (1) 2 spherical expansion part (2), top part (2>'
, the film thickness at the fin (3), the inner diameter (X) (Y) (Z) at each part, the overall length (J, and the length up to the fin (m)) Some examples of the relationship are shown below, but the relationship is not limited thereto.

−9= 破れ防止膜(4)は、膨脹部(2)に薄膜状に形成する
もので、膨脹部(2)と同質の天然ゴム又はシリコンゴ
ム、CR,SBRのような合成ゴムなどを塗布又は付着
させて膨脹部(2)と接着性が極めてよく一緒に伸縮し
剥離しないもので、その膨脹部(2)の頂面(2)′が
好ましいが、透視性やレーザー光線の透過性に支障がな
(プれば頂面に限らず広い面積に形成しても良く、又、
多少肉厚状であってもよい。いわゆる膨服部(2)が仮
りに破れても、破片が飛散することなく、収縮作用の働
くものである。
-9= The tear prevention film (4) is formed in the form of a thin film on the expansion part (2), and is coated with natural rubber, silicone rubber, synthetic rubber such as CR, SBR, etc. of the same quality as the expansion part (2). Or, it is attached to the expanded part (2) and has extremely good adhesion, expands and contracts together and does not peel off, and the top surface (2)' of the expanded part (2) is preferable, but it interferes with transparency and laser beam permeability. (If you press it, you can form it not only on the top surface but also on a wide area,
It may be somewhat thick. Even if the so-called inflatable part (2) were torn, the shrinking action would still work without any fragments being scattered.

尚は、第8図、第12図、第13図の如く、固定部(1
)と膨脹部(2)との間や膨服部(2)の先端部或いは
膨脹部を三方するように、適宜数の補強凸条(5)を設
(プたり肉厚部を設りたすすることも任意である。
In addition, as shown in Fig. 8, Fig. 12, and Fig. 13, the fixed part (1
) and the inflatable part (2), or on three sides of the tip of the inflatable part (2) or the inflatable part. It is also optional.

以上の如く構成よりなるバルーンは、内視鏡(C)のチ
ューブ(C)を装着せしめるカテーテル(B)の先端部
(b)に取付けるもので、該カテーテル(B)は此種の
技術分野において周知の 11 一 形態および構造のウレタン、ポリプロピレン、塩化ビニ
ル、ゴム、シリコンなどJ:す4するパイプ状のもので
あり、このカテーテル(B)の内部に内視1N(C)の
ヂ」−−ブ(C)又は光ファイバー(10)を挿入装着
せしめ、そのカテーテル(B)の先端部(b)に透明f
!I薄膜本体(△)を固着せしめる。内視鏡(C)の先
端RJ(には対物レンズ(6)及びこの対物レンズ(6
)の視野を照らすための二本のライ1〜ガイド(7)(
7)があって、処置具や鉗子などの治療具を挿入するチ
レンネル(8)或tま送気送水口(9)が開口しており
、カテーテル及び内視鏡ザ]−−ブ(C)の先端は臓器
や血管の内にa3いて上下左右に自由に動かづことが出
来、レーザー光線を照射J−る揚台には、そのチャンネ
ル〈8)に光ファイバー(10)を挿入して照射ゼしめ
る1、このカテーテルの先端部(b)の外面に凸起、凸
条又は凹条などの凹凸部(11〉を設りてJべり止めと
することは自由である。
The balloon constructed as described above is attached to the tip (b) of the catheter (B) to which the tube (C) of the endoscope (C) is attached, and the catheter (B) is used in this type of technical field. Well-known 11 Urethane, polypropylene, vinyl chloride, rubber, silicone, etc. in one form and structure. A catheter (C) or an optical fiber (10) is inserted and attached, and a transparent fiber is attached to the distal end (b) of the catheter (B).
! I Fix the thin film body (△). The tip RJ of the endoscope (C) has an objective lens (6) and this objective lens (6).
) two lies 1 to guide (7) to illuminate the field of view (
7), the tunnel (8) or air/water supply port (9) for inserting treatment tools such as treatment instruments and forceps is open, and the catheter and endoscope (C) are opened. The tip of the laser beam is placed inside the organ or blood vessel and can be moved freely up, down, left and right, and the optical fiber (10) is inserted into the channel (8) of the platform where the laser beam is irradiated. 1. It is free to provide unevenness (11) such as protrusions, protrusions, or grooves on the outer surface of the distal end (b) of this catheter to prevent the catheter from slipping.

凹凸部(11H;Lカテーテル(B)の先端部の外面に
、多数の凹起や四部或いは縦条、横条、リング状などの
多数の独立した又は連続した凸条又は凹条を形成したも
ので、その形態は任意であり、この凹凸部に固定部(1
)を係止J′るJ:うに被覆せしめると強固に取付ける
ことが可能となる。
Irregularities (11H; L catheter (B) with many independent or continuous protrusions or grooves formed on the outer surface of the tip of the catheter (B), such as four parts, vertical stripes, horizontal stripes, ring shapes, etc.) The shape is arbitrary, and the fixing part (1
) can be securely attached by covering the sea urchin.

次に第17図乃至第20図について説明すると膨服部(
12)は前述の膨脹部(2)と同様に膜厚が010〜o
4omm稈度の天然ゴム又はシリコンゴムなどによりな
る透明性伸縮薄膜で、中空状に形成され、その中空状内
部に生理食塩水を注入JることにJzつて適当な大きさ
に彫版し、その透明性がさらに一層よくなり透視性を向
上させると共に光ファイバー(10)からのレーザー光
線の透過も良好となるものであり、この膨服部(12)
の間口部(13)内面に取付リング(14)を固着し、
カテーテル(B)の先端部(b)に取イζIIノるファ
イバー支持具(d)に着脱自在に螺合する。
Next, to explain about FIGS. 17 to 20, the swelling part (
12) has a film thickness of 010 to 0, similar to the expansion part (2) described above.
It is a transparent stretchable thin film made of natural rubber or silicone rubber with a culm thickness of 4 mm, and is formed into a hollow shape. Physiological saline is injected into the hollow interior, and then it is engraved to an appropriate size. Transparency is further improved, improving visibility, and the transmission of laser beams from the optical fiber (10) is also improved, and this expanded portion (12)
Fix the mounting ring (14) to the inner surface of the frontage part (13),
The distal end (b) of the catheter (B) is removably screwed onto the fiber support (d).

取付リング(14)は膨脹部(12)をカテーテル(B
)の先端部(b)に取付けるためのもので、該リングの
内面には螺子を刻設して、ファイバー支持具(d)に螺
合自在とし、外面には膨服部−13= (12)の開口部(13)を接着剤などで固着して膨y
部と一体的な形態とする。
The attachment ring (14) connects the inflatable part (12) to the catheter (B
), and a screw is cut into the inner surface of the ring so that it can be freely screwed onto the fiber support (d), and the outer surface has a bulging part -13= (12) Secure the opening (13) with adhesive or the like and inflate it.
The structure shall be integrated with the department.

光フッフィバ−(10)は此種の技術分野で周知の形態
および構造のもので、カテーテル(B)内に光ファイバ
ー(10)又は内視鏡(C)のチューブ(C)が挿通さ
れており、光ファイバー(10)はヤグレーザ−、アル
ゴンレーザー、アルゴンダイレーザーなどのレーザー光
線を透過出来、カテーテル(B)の先端部(b)におい
て支持具(d)に支持されている。ファイバー支持具(
d)はカテーテル(B)の先端内面に固着して光ノア・
イバ−(io)を支持するもので、先端外部には取付リ
ング(14)の螺子と螺合する螺子を刻設してなり、内
面には生理食塩水を通ず溝又は孔(C′)を適宜敷設【
プ、カテーテル(B)内に直接或いは内視鏡(C)のヂ
11ンネル又は送気送水[1から1−即食塩水を流入し
てカテーテル及び孔(d’)から膨脹部(12)に注入
充填けしめる。
The optical fiber (10) has a form and structure well known in this type of technical field, and an optical fiber (10) or a tube (C) of an endoscope (C) is inserted into the catheter (B). The optical fiber (10) can transmit laser beams such as YAG laser, argon laser, argon dye laser, etc., and is supported by a support (d) at the distal end (b) of the catheter (B). Fiber support (
d) adheres to the inner surface of the tip of catheter (B) and
It supports the fiber (io), and has a screw carved into the outside of the tip to engage with the screw of the attachment ring (14), and a groove or hole (C') on the inner surface that does not allow saline to pass through. Lay it out as appropriate [
Directly into the catheter (B) or through the endoscope (C) channel or air/water supply [1 to 1- Immediate saline is injected into the inflated part (12) through the catheter and hole (d'). Injection filling.

前記膨脹部(12)に生理食塩水が注入されることによ
って彫版し、透視性がさらによくなると共に、Vグレー
ザー、アルインレー11−.アルゴンダイレーザーなど
のレーザー光線の透過もよくなる。又、この膨らみで出
血部位又は病巣を圧迫したり、狭窄部を拡開したり或い
は血管の内面に密接して血液の流れを止めたりづ−る。
The engraving is performed by injecting physiological saline into the expanded portion (12), which improves the transparency and improves the visibility of the V-glazer, Al-inlay 11-. It also improves the penetration of laser beams such as argon dye laser. This bulge also presses on bleeding sites or lesions, widens stenotic areas, or comes into close contact with the inner surface of blood vessels to stop blood flow.

次に上記構成のバルーンの製造方法について説明すると
、天然ゴムラテックスに粉末加硫剤と粉末加硫促進助剤
を少量配合して、粉末添加剤をできる限り抑え、液状加
硫促進剤と液状老化防止剤とを添加した配合溶液に成形
型を浸漬するものである。
Next, to explain the manufacturing method of the balloon with the above structure, a small amount of powdered vulcanizing agent and powdered vulcanization accelerator are blended into natural rubber latex, the amount of powder additives is suppressed as much as possible, and liquid vulcanization accelerator and liquid aged The mold is immersed in a mixed solution containing an inhibitor.

配合溶液は天然ゴムラテックスのゴム分1()0千吊部
に対して粉末加硫剤07〜1.5重字部好ましくは08
〜12重量部、粉末加硫促進助剤0.2−05重間部好
ましくは03〜04重最部と、液状加硫促進剤05〜2
0重量部、液状老化防止剤05〜20重量部を添加して
なるもので、そのl!ii!合方法は分散した加硫剤及
び加硫促進助剤を天然ゴムラテックスに添加し、混合攪
拌した後、加硫促進剤および老化防止剤を添加し、10
・〜1;)℃の恒温槽中に12〜24時間放置した後、
更に25〜35℃の恒温槽中で24〜48時間放置して
熟成さ1!る。
The blended solution should contain 07 to 1.5 parts of the powder vulcanizing agent per 1 () 0,000 parts of rubber of the natural rubber latex, preferably 08 parts.
~12 parts by weight, 0.2-05 parts of powder vulcanization accelerator, preferably 03-04 parts, and 05-2 parts of liquid vulcanization accelerator
0 parts by weight, and 05 to 20 parts by weight of a liquid anti-aging agent. ii! The mixing method is to add the dispersed vulcanizing agent and vulcanization accelerator to natural rubber latex, mix and stir, and then add the vulcanization accelerator and anti-aging agent.
・After being left in a constant temperature bath at ~1;)℃ for 12 to 24 hours,
Furthermore, it is left to mature for 24 to 48 hours in a constant temperature bath at 25 to 35 degrees Celsius. Ru.

成形型は所定の大ぎさ、形状をし1こ本体を得るための
いわゆる浸油製造型であり、この成形型を凝固剤に浸漬
してから前記配合溶液に30〜60秒間程度浸漬した後
、ゆっくり引き揚げて天然ゴムを0.10−一〇、40
層程度1i11着さけ、80〜90℃でζ30分間加熱
加硫して薄膜状とし、剥離粉などを用いて脱型し、この
型を洗浄、乾燥して再度、初めの凝固剤に浸漬さ仕これ
を繰り返し行なうものである。
The mold is a so-called oil immersion mold for obtaining a single body with a predetermined size and shape, and this mold is immersed in a coagulant and then immersed in the mixed solution for about 30 to 60 seconds, and then Slowly pull up natural rubber 0.10-10,40
After forming a layer of 1x11, heat and vulcanize at 80 to 90°C for 30 minutes to form a thin film, remove the mold using release powder, wash the mold, dry it, and re-immerse it in the original coagulant. This is done repeatedly.

脱型した肋膜状本体は洗浄した後、シリローンエマルジ
]ン処理して透明感を出し、80℃で60分程度乾燥u
しめ所定の長さに[1元カッティングを行う。この透明
薄膜本体(A)は、固定部(1)の先に伸縮自在で膨脹
可能な膨服部(2)を同一体に設【−ノたしので、固定
部(1)は−万端を開放状どした内径10〜17.0m
m程度の筒形状をしており、膨脹部(2)から透視し、
ノJチーチルの中に装着する内視鏡に形成しであるチャ
ンネル(8)又は送気送水口(9)或いはカテーテル自
身の注入口から生理食塩水を注入することによって、透
明性膨脹部(2)を所定の大きさに膨脂する球状体又は
膨出体或いは筒状体である。この場合前述した如く膨服
部は前記固定筒部より大径状に形成するか、小径状又は
同径状とするかは任意であり、又は膨脹部と固定筒部ど
の間に小径状のくびれ部又は補強凸条リングを同一体に
設Cプることも可能である。その内径も0.9〜35.
0mm稈度ど診断や治療する場所に応じて適宜人きさの
ものを選び、いずれにしても生理食塩水の注入によって
膨服し薄膜がさらに薄くなって透視が一層よくなると共
にレーザー光線が透過出来るものである。
After washing the demolded pleural body, it was treated with silylone emulsion to give it a transparent appearance, and dried at 80°C for about 60 minutes.
Perform one-piece cutting to the specified length. This transparent thin film main body (A) has a telescopic and inflatable inflatable part (2) disposed at the end of the fixed part (1) in the same body. Conditioned inner diameter 10-17.0m
It has a cylindrical shape of about m in diameter, and when seen through the expansion part (2),
By injecting physiological saline through the channel (8) formed on the endoscope to be installed in the catheter, the air/water supply port (9), or the injection port of the catheter itself, the transparent inflatable portion (2) is injected. ) is a spherical body, a bulging body, or a cylindrical body that expands the fat to a predetermined size. In this case, as described above, the inflatable portion may be formed to have a larger diameter, smaller diameter, or the same diameter than the fixed cylindrical portion, or a small diameter constriction may be formed between the inflatable portion and the fixed cylindrical portion. Alternatively, it is also possible to provide the reinforcing convex ring in the same body. Its inner diameter is also 0.9~35.
Choose a human-sized one depending on the location of diagnosis and treatment, such as a culm size of 0 mm, and in any case, it will swell by injecting physiological saline, making the thin film even thinner, making it even better to see through, and allowing the laser beam to pass through. It is.

具体的実施の態様 天然ゴムラテックス   ゴム分 (シス−1,4−ポリイソプレン)100千吊部加硫剤
(コロイド硫黄)1.2重量部 粉末加硫促進助剤(酸化亜鉛)   0.35重バ1部
加硫促進剤 (ジヂオカルバメー1〜系)087重量部老化防止剤 (パラフィンエマルジョン)   10重量部からなる
配合溶液を用いる。
Specific embodiments Natural rubber latex Rubber content (cis-1,4-polyisoprene) 100,000 parts Vulcanizing agent (colloidal sulfur) 1.2 parts by weight Powder vulcanization accelerator (zinc oxide) 0.35 parts by weight A blended solution consisting of 1 part vulcanization accelerator (didiocarbame 1-based), 087 parts by weight anti-aging agent (paraffin emulsion) 10 parts by weight is used.

成形型を10%硝酸カルシウム・メタノールを添加ぜる
室温の凝固剤溶液にゆっくり浸漬して直ちにゆっくり引
き揚げた後、前記配合溶液にゆっくり浸漬して室温で3
0〜60秒後ゆっくり引き揚げ、天然ゴムを付着させ8
0℃で30分間加熱加硫して、膜厚が0.1f3g、内
径が1.94mmの固定部と、その先に膜厚が0.22
 m、内径が154厚のくびれ部を介して膜厚がo、1
6馴、内径が1.81mの球状膨服部が同一体で、かつ
膨服部の頂面の膜厚が0.19mとなった薄膜状物とし
、該薄膜状物を剥頗粉を用いて脱型して40”−50°
Qの循環渇水中で約24時間抽出後10%シリコンエマ
ルジョンに室温でまlυべ/uなくつ【プ80℃で60
分間乾燥し透明感のづぐれた透明性薄膜本体を得た。
The mold was slowly immersed in a coagulant solution containing 10% calcium nitrate and methanol at room temperature, immediately pulled up slowly, and then slowly immersed in the above-mentioned mixed solution for 3 hours at room temperature.
After 0 to 60 seconds, slowly lift it up and attach natural rubber.8
After heating and vulcanizing at 0℃ for 30 minutes, a fixed part with a film thickness of 0.1f3g and an inner diameter of 1.94mm was formed, and a film thickness of 0.22mm was formed beyond that.
m, the film thickness is o, 1 through the constriction with an inner diameter of 154
6, the spherical swelling part with an inner diameter of 1.81 m is the same, and the film thickness on the top surface of the swelling part is 0.19 m, and the thin film material is removed using peeling powder. Mold 40”-50°
After extraction for about 24 hours in Q's circulating dry water, soak it in a 10% silicone emulsion at room temperature.
After drying for a few minutes, a transparent thin film body with poor transparency was obtained.

以上の様に浸漬成形した透明性薄膜本体(A)は上記寸
法、肉厚に限定されるものではなく図面に示J“如く固
定部(1)の先部に膨服部(2)を同一体に形成し必要
に応じて両者(1)(2)間にくびれ部(3)又は補強
凸部(/I)を設りた任意形態及び寸法、肉厚のもので
あり、前述け−るにうにこの本体(A)をカテーテル(
B)の先端部(b)に固定して彫版部が突出するように
取(=J +づるものである。
The transparent thin film main body (A) dip-molded as described above is not limited to the above dimensions and wall thickness, and as shown in the drawing, a swelling part (2) is attached to the tip of the fixing part (1). It is of any shape, size, and thickness, with a constriction (3) or reinforcing protrusion (/I) between the two (1) and (2) as necessary. Insert the sea urchin body (A) into the catheter (
It is fixed to the tip (b) of B) so that the engraved part protrudes (=J+).

(発明の効果) 本発明は固定部の先に彫版部を同一体に形成して透明性
薄膜本体を設け、この本体をカテーテルの先端部に取付
けて彫版部が該先端部より突出して被覆せしめ、彫版部
に生理食塩水を流入することにJ:って彫版させ、レー
ザー光線を透過せしめると共に透視可能としたから、該
本体をカテーテルの先端に取付(プることによって、そ
の内部に装着した内視鏡のチューブが直接、血液や体?
i!2などと接触しないために衛生的であり、しか−6
1その先端にあるライ1〜ガイド、対物レンズ、光)i
・イバーなどが保護され血液や分泌物などが附肴覆るこ
となく充分各機能を発揮し得る。又、カブ−アル内に挿
入装着し7.−内視鏡のヂャンネル又は送気送水口或い
はカテーテルの流入口から生理食塩水を流入ぜしめて彫
版部をふくらませることにより、所定の空間部が出来る
ために視野が広くなり、観察及び診断、或いは治療が容
易にかつ確実に行い得る。従って、例えば、血栓病等の
病巣を診断し、又、病巣にレーザ“−光線を照射したり
、或いは食道静脈瘤の病巣又は胃・十二脂腸などの病巣
を圧迫して出血をおさえ止血せしめたり、若しくは狭窄
した部分を拡開し治療覆ることが出来る1、その仙台臓
器におりる患部にも光ファイバーを透過するヤグレーザ
−、アルゴンレーリ゛−,アルゴンダイレーザーなどの
レーザー光線を照射して出血を止めたり病巣を焼灼した
りして治療するか、或いは患部に薬液を注射或い(ま投
薬することなどが出来、新しい治療法の提供に役立つも
のである。
(Effects of the Invention) The present invention provides a transparent thin film main body by forming an engraved part at the end of a fixing part in the same body, and attaches this main body to the tip of a catheter so that the engraved part protrudes from the tip. By engraving the coating and flowing physiological saline into the engraved part, the body was engraved to allow the laser beam to pass through and to be seen through.The body was attached to the tip of the catheter (by pulling it), and the inside of the body was engraved. Is the tube of the endoscope attached to the body directly connected to blood or the body?
i! It is hygienic because it does not come into contact with other substances such as 2, etc., and only -6
1 Lie at the tip 1 ~ guide, objective lens, light) i
・It protects the blood and secretions and allows the body to perform its functions without being covered by blood or secretions. Also, insert it into the cabo-al and 7. - By inflating the engraving by infusing physiological saline through the channel of the endoscope, the air and water supply port, or the inlet of the catheter, a predetermined space is created and the field of view becomes wider, making it easier for observation and diagnosis, or Treatment can be performed easily and reliably. Therefore, for example, by diagnosing a focus of thrombotic disease, etc., by irradiating the focus with a laser beam, or by compressing the focus of esophageal varices or the focus of the stomach, duodenum, etc., to suppress bleeding and stop the bleeding. 1. Laser beams such as Yag laser, argon ray, and argon dye laser that pass through optical fibers are irradiated to the affected area in the Sendai organ to prevent bleeding. It can be treated by stopping the disease, cauterizing the lesion, or by injecting or administering a medicinal solution to the affected area, which is useful in providing new treatment methods.

又、血管内において(ま血液の流れを止めることが出来
るため、血液流水防止用に別の個所を切開する必要がな
く、ス1〜ツバー用のカテーテルを挿入することも不要
である。
In addition, since the flow of blood can be stopped within the blood vessel, there is no need to make an incision at another location to prevent blood flow, and there is no need to insert a catheter for blood vessels.

更に透明性薄膜本体を浸潤成形によって筒状固宇部の一
方にくびれ部を介して球状膨服部を同一体に形成し、該
くびれ部の膜厚を固定部及び膨服部の膜厚よりも肉厚状
に設(プてなるから、該本体の整形が極めて良好である
と共に、球状膨服部を彫版せしめる際に、くびれ部が締
イ」効果を発揮し、そのの先部に位置する膨服部が容易
に膨らむことが出来る。
Furthermore, a spherical expanded portion is formed on one of the cylindrical solid portions through a constricted portion by infiltration molding of the transparent thin film body, and the film thickness of the constricted portion is made thicker than that of the fixed portion and the expanded portion. Because it is arranged in a shape, the shaping of the main body is extremely good, and when engraving the spherical swelling part, the constriction has a tightening effect, and the swelling part located at the tip of the spherical swelling part has a tightening effect. can be easily inflated.

しかも、彫版部に破れ防止膜を設置′JることにJ:っ
て薬液の注射や投薬に際してtJ:11)1針を用いた
り、レーザー光線の照射に光ファイバーを用いたりする
際、注射針を彫版部に刺してb、また、光ファイバーが
彫版部に当っても破裂することが少なく、仮りに破裂し
てもその破片が血管内や臓器内に飛散することを防止し
得て、彫版部を収縮さけるものとなる。
Furthermore, by installing a tear-prevention film on the engraving area, when using a single needle when injecting or administering a drug solution, or when using an optical fiber for laser beam irradiation, In addition, even if the optical fiber hits the engraving, it is less likely to rupture, and even if it ruptures, the fragments can be prevented from scattering into the blood vessels or organs, and the engraving can be carried out. This will prevent the printing plate from shrinking.

また本発明は天然ゴムラテックスのゴム分100千邑部
に対し、粉末加硫剤0.7”−1,5重量部、粉末加硫
促進助剤0.2〜05重量部、液状加粒促進剤05〜2
0重量部、液状老化防止剤0.5・〜20重量部を添加
した配合溶液に、成形型を浸漬して加硫乾燥しでなるか
ら、透明性があってしかも強度が大である薄膜本体が得
られ、病巣の発見を見落すことなく、かつレーザー光線
の照射によって治療に多大な功績を示すものとなり、レ
ーザー光線の透過率が極めて大きく、耐久性のあるもの
である。
In addition, the present invention uses 0.7''-1.5 parts by weight of a powder vulcanizing agent, 0.2 to 05 parts by weight of a powder vulcanization accelerator, and a liquid granulation accelerator for 100,000 parts of rubber content of natural rubber latex. Agent 05-2
The mold is immersed in a mixed solution containing 0 parts by weight and 0.5 to 20 parts by weight of a liquid anti-aging agent and vulcanized and dried, resulting in a thin film body that is transparent and has great strength. It is possible to achieve this without overlooking the discovery of lesions, and to achieve great results in treatment through laser beam irradiation.The laser beam has an extremely high transmittance and is durable.

【図面の簡単な説明】[Brief explanation of the drawing]

図面ば本発明のカテーテル用バルーンの実施の数形態例
を示すもので第1図は縦断正面図、第2図及び第3図は
(2)−(2)線及び(3)=(3)線に沿える断面図
、第4図は内視鏡のデユープを内部に装着したカテーテ
ルの先端に取付(づた状態図、第5図は血管内に挿入し
彫版部を膨らました状態図、第6図乃至第13図は他の
実施形態図、第14図はカテーテル先端におりる内視鏡
デユープの正面図、第15図及び第16図はカテーテル
の先端に取付りた仙の実施形態図、第17図は内視鏡を
省略し光ファイバーを取付りた状態の縦断正面図、第1
8図は(18)−(18)線に沿える断面図、第19図
は分解した状態の断面図、第20図は血管内−22= に挿入しvJ@部を膨らました状態の拡大図であり、図
中(A>は透明性薄膜本体、(B)はノJチーチル、(
C)は内視鏡、(c)はそのチューブ、(1)は固定部
、(2)は膨服部、(3)はくびれ部、(4)は破れ防
水膜である。 特許出願人  オカモ1〜株式会社
The drawings show several embodiments of the catheter balloon of the present invention, and FIG. 1 is a longitudinal sectional front view, and FIGS. 2 and 3 are lines (2)-(2) and (3)=(3). A cross-sectional view along the line, Figure 4 is a diagram with the endoscope duplex attached to the tip of the catheter attached inside, Figure 5 is a diagram with the endoscope inserted into a blood vessel and the engraved part is inflated, Figures 6 to 13 are views of other embodiments, Figure 14 is a front view of the endoscope duplex attached to the tip of the catheter, and Figures 15 and 16 are embodiments of the endoscope attached to the tip of the catheter. Fig. 17 is a longitudinal sectional front view with the endoscope omitted and the optical fiber attached.
Figure 8 is a cross-sectional view taken along line (18)-(18), Figure 19 is a cross-sectional view of the disassembled state, and Figure 20 is an enlarged view of the vJ@ section inserted into the blood vessel -22= and inflated. In the figure, (A> is the transparent thin film body, (B) is NoJ Chichiru, (
C) is an endoscope, (c) is its tube, (1) is a fixed part, (2) is an inflatable part, (3) is a constriction part, and (4) is a torn waterproof membrane. Patent applicant Okamo 1 ~ Co., Ltd.

Claims (7)

【特許請求の範囲】[Claims] (1)固定部の先に伸縮性の膨脹部を同一体に形成して
透明性薄膜本体を設け、この本体をカテーテルの先端部
に取付けて膨脹部が該先端部を突出状に被覆せしめ、膨
脹部に内視鏡のチューブを介して生理食塩水を流入する
ことによつて膨脹させ、レーザー光線を透過せしめると
共に透視可能となることを特徴とするカテーテル用バル
ーン。
(1) A transparent thin film main body is provided by forming a stretchable inflatable part at the tip of the fixed part in the same body, and this main body is attached to the distal end of the catheter so that the inflatable part covers the distal end in a protruding manner, 1. A balloon for a catheter, which is inflated by flowing physiological saline into the inflatable portion through a tube of an endoscope, and is transparent to a laser beam and can be seen through the balloon.
(2)固定部の先に膨脹部を同一体に形成して透明性薄
膜本体を設け、この固定部を任意の断面形状の筒状にす
ると共に膨脹部を中空状の球状体又は膨出体或いは筒状
体とした第1項記載のカテーテル用バルーン。
(2) An inflatable part is formed in the same body at the tip of the fixing part, and a transparent thin film body is provided, and the fixing part is made into a cylindrical shape with an arbitrary cross-sectional shape, and the inflatable part is made into a hollow spherical body or a bulging body. Alternatively, the catheter balloon according to item 1, which is formed into a cylindrical body.
(3)透明性薄膜本体を浸漬成形によって、筒状固定部
の一方にくびれ部を介して球状膨脹部を同一体に形成し
、該くびれ部の膜厚を固定部及び膨脹部の膜厚よりも肉
厚状に設けたことを特徴とする第1項又は第2項記載の
カテーテル用バルーン。
(3) A spherical expanding part is formed on one side of the cylindrical fixing part through a constriction part by dip molding the transparent thin film main body, and the film thickness of the constriction part is made larger than the film thickness of the fixing part and the expanding part. 2. The balloon for a catheter according to claim 1 or 2, characterized in that the balloon has a thick wall.
(4)本体を透明性伸縮薄膜で固定部の先に膨脹部を同
一体に形成し、この膨脹部に破れ防止膜を設けたことを
特徴とする第1項〜第3項記載のカテーテル用バルーン
(4) A catheter according to items 1 to 3, characterized in that the main body is made of a transparent stretchable thin film, and an inflatable part is formed in the same body at the tip of the fixing part, and a tear-preventing film is provided on the inflatable part. balloon.
(5)本体を透明性伸縮薄膜で筒状固定部の一方にくび
れ部を介して球状膨脹部を同一体に形成し、該くびれ部
の膜厚を固定部及び膨脹部の膜厚よりも肉厚状に設ける
と共に膨脹部の径を固定部の径よりも小径としかつ膨脹
部に破れ防止膜を設けた第1項〜第2項記載のカテーテ
ル用バルーン。
(5) The main body is made of a transparent stretchable thin film, and a spherical expansion part is formed on one side of the cylindrical fixed part through a constriction part, and the film thickness of the constriction part is made thicker than that of the fixed part and the expansion part. 3. The balloon for a catheter according to items 1 and 2, wherein the balloon is thick, the diameter of the inflatable part is smaller than the diameter of the fixed part, and the inflatable part is provided with a tear-preventing membrane.
(6)透明性伸縮薄膜で中空状の膨脹部を形成し、この
膨脹部の開口部内面に取付リングを固着し、この取付リ
ングをカテーテルの先端に形成した取付部に螺合自在と
したカテーテル用バルーン。
(6) A catheter in which a hollow expansion part is formed with a transparent stretchable thin film, a mounting ring is fixed to the inner surface of the opening of the expansion part, and the mounting ring can be freely screwed into the mounting part formed at the tip of the catheter. balloon.
(7)天然ゴムラテックスのゴム分100重量部に対し
、粉末加硫剤0.7〜1.5重量部、粉末加硫促進助剤
0.2〜0.5重量部、液状加硫促進剤0.5〜2.0
重量部、液状老化防止剤0.5〜2.0重量部を添加し
て配合溶液を構成し、この溶液に成形型を浸漬して天然
ゴムを付着させ、加硫乾燥後、脱型し、筒状固定部の先
に膨脹部を同一体に形成した透明性薄膜本体からなるカ
テーテル用バルーンの製造方法。
(7) Per 100 parts by weight of the rubber content of natural rubber latex, 0.7 to 1.5 parts by weight of powder vulcanizing agent, 0.2 to 0.5 parts by weight of powder vulcanization accelerator, and liquid vulcanization accelerator 0.5-2.0
parts by weight, and 0.5 to 2.0 parts by weight of a liquid anti-aging agent are added to form a compounded solution, a mold is immersed in this solution to adhere natural rubber, and after vulcanization and drying, the mold is demolded. A method for manufacturing a catheter balloon comprising a transparent thin film main body in which an inflatable part is integrally formed at the tip of a cylindrical fixing part.
JP63164196A 1988-06-30 1988-06-30 Balloon for catheter and manufacture thereof Pending JPH0213423A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63164196A JPH0213423A (en) 1988-06-30 1988-06-30 Balloon for catheter and manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63164196A JPH0213423A (en) 1988-06-30 1988-06-30 Balloon for catheter and manufacture thereof

Publications (1)

Publication Number Publication Date
JPH0213423A true JPH0213423A (en) 1990-01-17

Family

ID=15788505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63164196A Pending JPH0213423A (en) 1988-06-30 1988-06-30 Balloon for catheter and manufacture thereof

Country Status (1)

Country Link
JP (1) JPH0213423A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008212506A (en) * 2007-03-07 2008-09-18 Hoya Corp Distal end cap for endoscope and endoscope
JP2010125274A (en) * 2008-12-01 2010-06-10 Fujifilm Corp Optical probe instrument and method for controlling balloon of the same
JP2014217552A (en) * 2013-05-08 2014-11-20 コニカミノルタ株式会社 Fallopian tube access catheter and fallopian tube endoscope device
JP2015505678A (en) * 2011-09-22 2015-02-26 ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity System and method for visualizing ablated tissue

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58188421A (en) * 1982-04-27 1983-11-02 東レ株式会社 Balloon cathetel for vessel endoscope
JPS63111834A (en) * 1986-10-29 1988-05-17 オカモト株式会社 Production of transparent membrane balloon
JPS63315025A (en) * 1987-06-18 1988-12-22 Okamoto Kk Balloon for endoscope
JPS63315027A (en) * 1987-06-18 1988-12-22 Okamoto Kk Balloon for endoscope
JPS63317128A (en) * 1987-06-22 1988-12-26 Okamoto Kk Balloon for endoscope
JPS63318955A (en) * 1987-06-22 1988-12-27 Okamoto Kk Preparation of balloon for endoscope

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58188421A (en) * 1982-04-27 1983-11-02 東レ株式会社 Balloon cathetel for vessel endoscope
JPS63111834A (en) * 1986-10-29 1988-05-17 オカモト株式会社 Production of transparent membrane balloon
JPS63315025A (en) * 1987-06-18 1988-12-22 Okamoto Kk Balloon for endoscope
JPS63315027A (en) * 1987-06-18 1988-12-22 Okamoto Kk Balloon for endoscope
JPS63317128A (en) * 1987-06-22 1988-12-26 Okamoto Kk Balloon for endoscope
JPS63318955A (en) * 1987-06-22 1988-12-27 Okamoto Kk Preparation of balloon for endoscope

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008212506A (en) * 2007-03-07 2008-09-18 Hoya Corp Distal end cap for endoscope and endoscope
JP2010125274A (en) * 2008-12-01 2010-06-10 Fujifilm Corp Optical probe instrument and method for controlling balloon of the same
JP2015505678A (en) * 2011-09-22 2015-02-26 ザ・ジョージ・ワシントン・ユニバーシティThe George Washingtonuniversity System and method for visualizing ablated tissue
JP2014217552A (en) * 2013-05-08 2014-11-20 コニカミノルタ株式会社 Fallopian tube access catheter and fallopian tube endoscope device

Similar Documents

Publication Publication Date Title
US5029574A (en) Endoscopic balloon with a protective film thereon
JP6937775B2 (en) Minimally invasive methods and systems for hemostasis in bleeding closed tissue volume
US11819648B2 (en) Methods and devices to prevent premature birth
US20030191476A1 (en) Endoscope & tools for applying sealants and adhesives and intestinal lining for reducing food absorption
JPH09510480A (en) Injection molded PVA sponge
WO1996004033A1 (en) Microcatheter
JP4993519B2 (en) Organ model for surgical practice or for checking the sharpness of surgical resection tools
JP4675414B2 (en) Organ model
EP0857039B1 (en) Probe sheath
US20240009040A1 (en) Delivery systems for control of bleeding in transurethral prostatectomy
JPH0213423A (en) Balloon for catheter and manufacture thereof
EP0288576B1 (en) Balloon for endoscope
US20210059868A1 (en) Chitosan dressing for control of bleeding in transurethral prostatectomy
JPH07308388A (en) Ring-shaped balloon
JPH0233264B2 (en)
JPH0340244Y2 (en)
JPH0318904B2 (en)
CN208274834U (en) A kind of medical surgery surgical anaesthesia medicator
JPH034243Y2 (en)
JPH034242Y2 (en)
JPH0151264B2 (en)
RU2248776C2 (en) Method and device for treating complicated forms of ablatio retinae
JPS63315025A (en) Balloon for endoscope
CN218606705U (en) Intranasal self-expansion retractor in nerve endoscopic skull base operation
JP7495165B2 (en) Method of sealing damaged or holed areas of a corpse